Immunohistochemical evaluation of androgen receptor expression in endometrial carcinoma and its clinicopathological significance

• by Alaa saad Abd elhamid Mohamed, Heba Ashraf Hosni, Maram Salaheldeen Mahmoud, Alzahraa Abdelmoktader Mohammed

• September 26, 2026

Malignant transformation of lower-grade glioma: contrast enhancement, extent of resection, and the natural history under interval-censored analysis

• by Baran Atli, Maximilian Wartha, Matthias Gmeiner, Martin Aichholzer, Serge Weis, Dominik Vorhauer, Helga Wagner, Tanja Hauer, Carlo Serra, Petra Böhm, Michael Sonnberger, Nico Stroh-Holly, Stefan Aspalter, Kathrin Aufschnaiter, Tobias Rossmann, Maria Gollwitzer, Jawed Ziai, Annette Leibetseder, Josef Pichler, Wolfgang Thomae, Christian Dorfer, Andreas Gruber, Harald Stefanits, Philip Rauch

• September 22, 2026

A New Era for Pancreatic Cancer: How Baptist Health Research Helped Get Us Here

Pancreatic adenocarcinoma, the most common form of pancreatic cancer, accounts for roughly 90 to 95 percent of cases. It's notoriously difficult to catch early, because symptoms often don't appear until the disease has already spread

• by

• September 24, 2026

• 11 min

Current status and future directions of AI in prostate cancer detection on MRI: a special report from the ESUR prostate MRI working group authors

• by Renato Cuocolo, Andrea Ponsiglione, Georgios Agrotis, Tristan Barrett, Giorgio Brembilla, Iztok Caglic, Hanna Falińska, Charlie Alexander Hamm, Emanuele Messina, Tobias Penzkofer, Raphaële Renard-Penna, Olivier Rouvière, Luca Russo, Evis Sala, Johannes Uhlig, Anwar R. Padhani, Maarten de Rooij

• September 18, 2026